Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-07-31

FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

Supplemental approval for rosuvastatin calcium by Rising Pharma Holdings, Inc..

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ROSUVASTATIN CALCIUM (rosuvastatin calcium)

Snippet

SUPPL AP for ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM)